SOPHYSA
2 recall(s) on record — most severe on record: Class II.
Activity by year
- Recalls (2)
- Inspections (3)
Devices registered here (1)
- Shunt, Central Nervous System And ComponentsProduct code JXG (opens in a new tab) · Class II · Neurology · 21 CFR 882.5550
Recalls & enforcement
- Class IIOngoing2025-11-17Customer complaints of Pressio monitor rebooting.
- Class IIOngoing2024-04-09An increase in claims related to leakage of cerebrospinal fluid (CSF) from the proximal end of the catheter. In the event of a leak going undetected during implantation, it could pose an infectious risk to the patient. The cause of the leaks is indicated to be manufacturing error…
FDA inspections (3)
- NAI2025-06-12No Action Indicated · Compliance: Devices; Postmarket Assurance: Devices · citations posted
- NAI2023-06-07No Action Indicated · Compliance: Devices
- NAI2019-01-31No Action Indicated · Compliance: Devices
Source: U.S. FDA Inspections Dashboard (opens in a new tab) (device inspection classifications, 2016–present). Data as of 2026-10-06. The dashboard profile can take several seconds to load.
Related
Source: U.S. FDA via openFDA (opens in a new tab) (device registration & enforcement). Data as of 2026-10-06. Verify this facility record at FDA → (opens in a new tab)
Cite this record
RegWarden. “SOPHYSA (FEI 3001587388) — FDA facility record.” Compiled from U.S. FDA public records (openFDA; FDA Data Dashboard). Data as of 2026-10-06. https://regwarden.com/facility/3001587388-sophysa/
Alerts for SOPHYSA
Watchlist alerts will email you when FDA publishes a new recall, inspection classification, or warning letter for a facility you follow. They aren't open to the public yet — leave your email and we'll tell you when they are.
Want a one-page facility brief?
A single-page summary of this facility's registration and recall history for diligence. Not selling it yet — register interest and we'll follow up.